Literature DB >> 23559880

Role of endolaryngeal surgery (with or without laser) compared with radiotherapy in the management of early (T1) glottic cancer: a clinical practice guideline.

J Yoo1, C Lacchetti, J A Hammond, R W Gilbert.   

Abstract

AIMS: To provide evidence-based practice guideline recommendations concerning the role of endolaryngeal surgery (with or without laser) compared with radiation therapy for patients with early (T1) glottic cancer, assessing survival, locoregional control, laryngeal preservation rates, and voice outcomes.
METHODS: The medline, embase, and Cochrane Library databases were searched to identify relevant studies from 1996 to 2011. Recommendations were formulated based on that evidence and on the expert opinion of Cancer Care Ontario's Head and Neck Cancer disease site group. The systematic review and practice guideline were externally reviewed by practitioners in Ontario, Canada.
RESULTS: The available evidence was of a level insufficient to demonstrate a clear difference between treatment options when considering the likelihood of local control or overall survival. Although the evidence was mainly retrospective, there was a suggestion that, compared with surgery, radiotherapy might be associated with less measureable perturbation of voice without a significant difference in patient perception. The likelihood of laryngeal preservation may be higher when surgery can be offered as initial treatment.
CONCLUSIONS: For patients with early (T1) glottic cancer, the evidence is insufficient to demonstrate a difference between endolaryngeal surgery (with or without laser) and external-beam radiation therapy. The choice between treatment modalities has been based on patient and clinician preferences and general medical condition.

Entities:  

Keywords:  Endolaryngeal; T1; glottic; radiotherapy; surgery

Year:  2013        PMID: 23559880      PMCID: PMC3615864          DOI: 10.3747/co.20.1237

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


  19 in total

1.  Current practice patterns in the management of glottic cancer in Canada: results of a national survey.

Authors:  Fawaz M Makki; Blair Williams; Murali Rajaraman; Robert D Hart; Jonathan Trites; Tim Brown; S Mark Taylor
Journal:  J Otolaryngol Head Neck Surg       Date:  2011-06

Review 2.  Treatment of early-stage glottic cancer: meta-analysis comparison of laser excision versus radiotherapy.

Authors:  Kevin M Higgins; Manish D Shah; Maurice J Ogaick; Danny Enepekides
Journal:  J Otolaryngol Head Neck Surg       Date:  2009-12

3.  Has radiotherapy become too expensive to be considered a treatment option for early glottic cancer?

Authors:  R L Foote; S J Buskirk; G L Grado; J A Bonner
Journal:  Head Neck       Date:  1997-12       Impact factor: 3.147

4.  Multidisciplinary approach in the treatment of T1 glottic cancer. The role of patient preference in a homogenous patient population.

Authors:  Nicola Dinapoli; Claudio Parrilla; Jacopo Galli; Rosa Autorino; Francesco Miccichè; Francesco Bussu; Mario Balducci; Lucia D'Alatri; Raffaella Marchese; Mario Rigante; Giuseppe Di Lella; Luca Liberati; Giovanni Almadori; Gaetano Paludetti; Vincenzo Valentini
Journal:  Strahlenther Onkol       Date:  2010-11-08       Impact factor: 3.621

Review 5.  Management of T1-T2 glottic carcinomas.

Authors:  William M Mendenhall; John W Werning; Russell W Hinerman; Robert J Amdur; Douglas B Villaret
Journal:  Cancer       Date:  2004-05-01       Impact factor: 6.860

6.  Voice-related quality of life after treatment of laryngeal cancer.

Authors:  Nobuhiko Oridate; Akihiro Homma; Seigo Suzuki; Yuji Nakamaru; Fumiyuki Suzuki; Hiromitsu Hatakeyama; Shigenari Taki; Tomohiro Sakashita; Noriko Nishizawa; Yasushi Furuta; Satoshi Fukuda
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2009-04

7.  Radiotherapy or CO(2) laser surgery as treatment of T(1a) glottic carcinoma?

Authors:  Vera Mahler; Morten Boysen; Kjell Brøndbo
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-11-08       Impact factor: 2.503

8.  Quality of life, functional outcome, and costs of early glottic cancer.

Authors:  Jonathan C Smith; Jonas T Johnson; David M Cognetti; Douglas P Landsittel; William E Gooding; Elmer R Cano; Eugene N Myers
Journal:  Laryngoscope       Date:  2003-01       Impact factor: 3.325

Review 9.  Health status and voice outcome after treatment for T1a glottic carcinoma.

Authors:  A Jeanne G E Peeters; Christine D L van Gogh; Kim M Goor; Irma M Verdonck-de Leeuw; Johannes A Langendijk; Hans F Mahieu
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-01-09       Impact factor: 2.503

10.  Challenging a dogma--surgery yields superior long-term results for T1a squamous cell carcinoma of the glottic larynx compared to radiotherapy.

Authors:  D Thurnher; B M Erovic; F Frommlet; W Brannath; K Ehrenberger; B Jansen; E Selzer; M C Grasl
Journal:  Eur J Surg Oncol       Date:  2007-08-08       Impact factor: 4.424

View more
  6 in total

1.  Treatment and survival in 10,429 patients with localized laryngeal cancer: a population-based analysis.

Authors:  Stephanie Misono; Schelomo Marmor; Bevan Yueh; Beth A Virnig
Journal:  Cancer       Date:  2014-03-17       Impact factor: 6.860

2.  Multicentric evaluation of strategies for treatment of T1a glottic carcinomas.

Authors:  Nicolas Fakhry; Sébastien Vergez; Karine Baumstarck; Aude Lagier; Laure Santini; Patrick Dessi; Emmanuel Babin; Antoine Giovanni
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-08-09       Impact factor: 2.503

3.  Analysis of failure following transoral laser surgery for early glottic cancer.

Authors:  Aviram Mizrachi; Naomi Rabinovics; Ohad Hilly; Jacob Shvero
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-03-05       Impact factor: 2.503

4.  Clinical practice guidelines and consensus statements in oncology--an assessment of their methodological quality.

Authors:  Carmel Jacobs; Ian D Graham; Julie Makarski; Michaël Chassé; Dean Fergusson; Brian Hutton; Mark Clemons
Journal:  PLoS One       Date:  2014-10-17       Impact factor: 3.240

5.  Human Papillomavirus Subtype 16 and the Pathologic Characteristics of Laryngeal Cancer.

Authors:  Mohammed Abdel Motaal Gomaa; Khalid Elsayed El Gindy; Usama Galal Abdel Nabi; Haitham M Mohammed; Nisreen A Abdel Twab; Rehab Mahmoud; Khalid M Mohiy
Journal:  OTO Open       Date:  2017-05-08

6.  Prognostic factors of patients with initially diagnosed T1a glottic cancer: Novel nomograms and a propensity-score matched cohort analysis.

Authors:  Meng-Si Luo; Guan-Jiang Huang; Hong-Bing Liu
Journal:  Medicine (Baltimore)       Date:  2020-11-06       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.